Evaluation of Phosphorylated Urinary Na-Cl Cotransporter Is Potentially Useful in a Patient With Pseudohypoaldosteronism Type II due to Mutation in

• Keiko Nagahara MD, PhD,
• Yoshifusa Abe MD, PhD,
• Akira Hojo MD,
• Kazushige Dobashi MD, PhD,
• Motoko Chiga,
• Kiyoshi Isobe MD, PhD,
• Shinichi Uchida MD, PhD,
• Kazuo Itabashi MD, PhD

Affiliations

Keiko Nagahara MD, PhD

Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan

Yoshifusa Abe MD, PhD

Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan

Akira Hojo MD

Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan

Kazushige Dobashi MD, PhD

Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan

Motoko Chiga

Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan

Kiyoshi Isobe MD, PhD

Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan

Shinichi Uchida MD, PhD

Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan

Kazuo Itabashi MD, PhD

Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan